SMTL ID : 3nu9.1

Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

homo-dimer

Ligands

1 x 478: {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER(Non-covalent)

478.1: 23 residues within 4Å: Chain A: D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, P.81, V.82 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, V.82, V.84 21 PLIP interactions: 12 interactions with chain A, 9 interactions with chain B Hydrophobic interactions: A:A.28, A:V.32, A:I.50, A:P.81, A:V.82, B:L.23, B:A.28, B:V.82, B:V.84 Hydrogen bonds: A:D.29, A:D.30, A:D.30, B:G.27, B:G.27, B:D.29, B:D.30 Water bridges: A:D.30, A:I.50, A:I.50 Salt bridges: A:D.25, B:D.25

30 x IOD: IODIDE ION(Non-functional Binders)

IOD.2: 2 residues within 4Å: Chain A: T.74, N.88 Ligand excluded by PLIP IOD.3: 2 residues within 4Å: Chain A: K.20, E.21 Ligand excluded by PLIP IOD.4: 3 residues within 4Å: Chain A: N.88, T.91 Chain B: W.6 Ligand excluded by PLIP IOD.5: 2 residues within 4Å: Chain A: T.12, A.67 Ligand excluded by PLIP IOD.6: 2 residues within 4Å: Chain A: K.7, R.8 Ligand excluded by PLIP IOD.7: 2 residues within 4Å: Chain A: I.54, K.55 Ligand excluded by PLIP IOD.8: 4 residues within 4Å: Chain A: T.12, E.65, A.67, G.68 Ligand excluded by PLIP IOD.9: 2 residues within 4Å: Chain A: Q.61, G.73 Ligand excluded by PLIP IOD.10: 1 residues within 4Å: Ligands: IOD.11 Ligand excluded by PLIP IOD.11: 3 residues within 4Å: Chain A: Q.18, S.37 Ligands: IOD.10 Ligand excluded by PLIP IOD.12: 4 residues within 4Å: Chain A: E.34, E.35, P.79, T.80 Ligand excluded by PLIP IOD.13: 2 residues within 4Å: Chain A: K.14, G.17 Ligand excluded by PLIP IOD.14: 1 residues within 4Å: Chain A: L.19 Ligand excluded by PLIP IOD.15: 1 residues within 4Å: Chain A: F.53 Ligand excluded by PLIP IOD.16: 1 residues within 4Å: Chain A: K.55 Ligand excluded by PLIP IOD.17: 2 residues within 4Å: Chain A: I.54, P.79 Ligand excluded by PLIP IOD.18: 3 residues within 4Å: Chain B: G.73, T.74, N.88 Ligand excluded by PLIP IOD.19: 1 residues within 4Å: Chain B: T.12 Ligand excluded by PLIP IOD.20: 1 residues within 4Å: Chain B: W.6 Ligand excluded by PLIP IOD.21: 1 residues within 4Å: Chain B: K.70 Ligand excluded by PLIP IOD.22: 3 residues within 4Å: Chain B: E.21, E.34, N.83 Ligand excluded by PLIP IOD.23: 1 residues within 4Å: Chain B: R.8 Ligand excluded by PLIP IOD.24: 2 residues within 4Å: Chain B: K.14, E.65 Ligand excluded by PLIP IOD.25: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP IOD.26: 1 residues within 4Å: Chain B: G.40 Ligand excluded by PLIP IOD.27: 4 residues within 4Å: Chain B: P.44, M.46, K.55 Ligands: IOD.31 Ligand excluded by PLIP IOD.28: 1 residues within 4Å: Chain B: R.41 Ligand excluded by PLIP IOD.29: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP IOD.30: 1 residues within 4Å: Chain B: K.7 Ligand excluded by PLIP IOD.31: 2 residues within 4Å: Chain B: P.44 Ligands: IOD.27 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shen, C.H. et al., Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters. Febs J. (2010)

Release Date

2010-08-25

Peptides

Protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Protease

Related Entries With Identical Sequence